These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 3196557)

  • 41. Automated regional citrate anticoagulation: technological barriers and possible solutions.
    Szamosfalvi B; Frinak S; Yee J
    Blood Purif; 2010; 29(2):204-9. PubMed ID: 20093828
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A safe citrate anticoagulation protocol with variable treatment efficacy and excellent control of the acid-base status.
    Morgera S; Schneider M; Slowinski T; Vargas-Hein O; Zuckermann-Becker H; Peters H; Kindgen-Milles D; Neumayer HH
    Crit Care Med; 2009 Jun; 37(6):2018-24. PubMed ID: 19384210
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Toward acid- and heparin-free dialysis: the regional anticoagulation approach.
    Lefevre F; Vial R; Grellier S; Bujon S; Bouchouareb D; Brunet P; Scarfoglière V; Robert T
    Clin Kidney J; 2024 Aug; 17(8):sfae201. PubMed ID: 39104871
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Is regional citrate superior to systemic heparin anticoagulation for continuous renal replacement therapy? A prospective observational study in an adult regional critical care system.
    Bagshaw SM; Laupland KB; Boiteau PJ; Godinez-Luna T
    J Crit Care; 2005 Jun; 20(2):155-61. PubMed ID: 16139156
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Evaluation of three different methods to prevent dialyzer clotting without causing systemic anticoagulation effect.
    Richtrova P; Rulcova K; Mares J; Reischig T
    Artif Organs; 2011 Jan; 35(1):83-8. PubMed ID: 20626736
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Clinical usefulness of Nephral ST dialyzers in hemodialyzed patients with increased risk of bleeding].
    Kopeć J; Sułowicz W
    Przegl Lek; 2010; 67(2):91-4. PubMed ID: 20557006
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Citrate anticoagulation for single-needle hemodialysis: safety and efficacy.
    Buturović-Ponikvar J; Gubensek J; Ponikvar R
    Ther Apher Dial; 2005 Jun; 9(3):237-40. PubMed ID: 15966997
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effects of citrate acid concentrate (citrasate®) on heparin N requirements and hemodialysis adequacy: a multicenter, prospective noninferiority trial.
    Sands JJ; Kotanko P; Segal JH; Ho CH; Usvat L; Young A; Carter M; Sergeyeva O; Korth L; Maunsell E; Zhu Y; Krishnan M; Diaz-Buxo JA
    Blood Purif; 2012; 33(1-3):199-204. PubMed ID: 22269855
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Heparin-coated polyacrylonitrile membrane versus regional citrate anticoagulation: a prospective randomized study of 2 anticoagulation strategies in patients at risk of bleeding.
    Evenepoel P; Dejagere T; Verhamme P; Claes K; Kuypers D; Bammens B; Vanrenterghem Y
    Am J Kidney Dis; 2007 May; 49(5):642-9. PubMed ID: 17472846
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Regional anticoagulation with citrate in hemodialysis in patients with a high risk for hemorrhage].
    Perdrix JP; Lepape A; Gronlier T; Grozel JM; Banssillon V
    Ann Fr Anesth Reanim; 1988; 7(1):31-5. PubMed ID: 3348512
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Citrate anticoagulation control by ionized calcium levels does not prevent hemostasis and complement activation during hemodialysis.
    Opatrný K; Richtrová P; Polanská K; Wirth J; Sefrna F; Brandl M; Falkenhagen D
    Artif Organs; 2007 Mar; 31(3):200-7. PubMed ID: 17343695
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Locking solutions for hemodialysis catheters; heparin and citrate--a position paper by ASDIN.
    Moran JE; Ash SR;
    Semin Dial; 2008; 21(5):490-2. PubMed ID: 18764795
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Regional anticoagulation with sodium citrate: chronic utilization in the hemodialysis patient].
    Collart F; Wens R; Dratwa M
    Nephrologie; 1993; 14(3):151-4. PubMed ID: 8367007
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Hemodialysis without anticoagulation.
    Sanders PW; Taylor H; Curtis JJ
    Am J Kidney Dis; 1985 Jan; 5(1):32-5. PubMed ID: 3881017
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Anticoagulation].
    Matsuda O
    Nihon Rinsho; 1991 Dec; 49 Suppl():279-86. PubMed ID: 1808269
    [No Abstract]   [Full Text] [Related]  

  • 56. Long-term citrate anticoagulation in chronic hemodialysis patients.
    Gubenšek J; Kovač J; Benedik M; Marn-Pernat A; Knap B; Ponikvar R; Buturović-Ponikvar J
    Ther Apher Dial; 2011 Jun; 15(3):278-82. PubMed ID: 21624076
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Biocompatibility of hemodialysis membranes: evaluation in an ovine model.
    Burhop KE; Johnson RJ; Simpson J; Chenoweth DE; Borgia J
    J Lab Clin Med; 1993 Feb; 121(2):276-93. PubMed ID: 8433041
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Initial evaluation of aluminum concentrations in patients with nephropathy and undergoing hemodialysis at the Miguel Pérez Carreño Hospital and the University Hospital of Caracas (Venezuela)].
    Parra OE; Navarro JA; de Ardila M; Weissinger J; Domínguez J; Gutiérrez LE; Carlini R; Mendoza JA; Salgado OJ; Romero RA
    Invest Clin; 1989; 30(4):193-203. PubMed ID: 2488708
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effect of anticoagulation on blood membrane interactions during hemodialysis.
    Hofbauer R; Moser D; Frass M; Oberbauer R; Kaye AD; Wagner O; Kapiotis S; Druml W
    Kidney Int; 1999 Oct; 56(4):1578-83. PubMed ID: 10504511
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A Randomized Controlled Trial of Regional Citrate Versus Regional Heparin Anticoagulation for Continuous Renal Replacement Therapy in Critically Ill Adults.
    Gattas DJ; Rajbhandari D; Bradford C; Buhr H; Lo S; Bellomo R
    Crit Care Med; 2015 Aug; 43(8):1622-9. PubMed ID: 25853591
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.